Some A-share biopharmaceutical stocks weakened, SHANGHAI YIZHONG fell over 7%, INNOCARE fell over 5%
In the A-share market, some biopharmaceutical stocks weakened, with Nanmo Biology down 9%, SHANGHAI YIZHONG down over 7%, INNOCARE down over 5%, Sunshine Novo Nordisk and Guangsheng Tang down over 4%, Haichuang Pharmaceutical, Baicheng Pharmaceutical, Yaokang Biology, and Qianyan Biology down over 3%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments